Brief Communication: A New Combination in the Treatment of Advanced Pancreatic Cancer
- 31 December 2005
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 32, 5-6
- https://doi.org/10.1053/j.seminoncol.2005.07.017
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A phase III trial of the National Cancer Institute of Canada Clinical Trials Group [NCIC-CTG]Journal of Clinical Oncology, 2005
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.Journal of Clinical Oncology, 1997